Your new post is loading...
It is not clear whether TNF-α antagonists used in the treatment of psoriasis need to act systemically, or whether local inhibition of skin-produced TNF-α would be sufficient to silence skin inflammation.
|
Suggested by Société Francaise d'Immunologie |
Scoop.it!
Gilbert C FAURE's insight:
topical
No comment yet.
Sign up to comment
